Projected to grow from US$31.27 billion in 2024 to US$56.62 billion by 2033 at 6.8% CAGR, the rheumatoid arthritis drugs market thrives on hormonal influences and women's higher prevalence. Dive into segmentation by drug class, key innovations, and challenges in joint preservation. https://au.finance.yahoo.com/news/rheumatoid-arthritis-drugs-market-size-155000726.html